1. Home
  2. EYPT vs HDL Comparison

EYPT vs HDL Comparison

Compare EYPT & HDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • HDL
  • Stock Information
  • Founded
  • EYPT 1987
  • HDL 2016
  • Country
  • EYPT United States
  • HDL Singapore
  • Employees
  • EYPT N/A
  • HDL N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • HDL Restaurants
  • Sector
  • EYPT Industrials
  • HDL Consumer Discretionary
  • Exchange
  • EYPT Nasdaq
  • HDL Nasdaq
  • Market Cap
  • EYPT 967.4M
  • HDL 1.1B
  • IPO Year
  • EYPT 2005
  • HDL 2024
  • Fundamental
  • Price
  • EYPT $14.50
  • HDL $17.71
  • Analyst Decision
  • EYPT Strong Buy
  • HDL
  • Analyst Count
  • EYPT 5
  • HDL 0
  • Target Price
  • EYPT $29.60
  • HDL N/A
  • AVG Volume (30 Days)
  • EYPT 1.4M
  • HDL 2.0K
  • Earning Date
  • EYPT 11-05-2025
  • HDL 11-26-2025
  • Dividend Yield
  • EYPT N/A
  • HDL N/A
  • EPS Growth
  • EYPT N/A
  • HDL 197.81
  • EPS
  • EYPT N/A
  • HDL 0.09
  • Revenue
  • EYPT $42,339,000.00
  • HDL $805,433,000.00
  • Revenue This Year
  • EYPT N/A
  • HDL $11.22
  • Revenue Next Year
  • EYPT N/A
  • HDL $13.44
  • P/E Ratio
  • EYPT N/A
  • HDL $196.73
  • Revenue Growth
  • EYPT N/A
  • HDL 9.65
  • 52 Week Low
  • EYPT $3.91
  • HDL $15.54
  • 52 Week High
  • EYPT $14.91
  • HDL $30.00
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 65.45
  • HDL 52.07
  • Support Level
  • EYPT $13.43
  • HDL $17.20
  • Resistance Level
  • EYPT $14.67
  • HDL $17.77
  • Average True Range (ATR)
  • EYPT 0.91
  • HDL 0.26
  • MACD
  • EYPT 0.32
  • HDL 0.12
  • Stochastic Oscillator
  • EYPT 99.54
  • HDL 100.00

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

Share on Social Networks: